Immunovant Inc (IMVT)

26.87 +0.33 (+1.24%) USD  |  NASDAQ  |  Nov 22, 16:00
26.88 +0.01 (+0.04%) After-Hours: 20:00
More

Immunovant EPS Diluted (Quarterly): -0.74 for Sept. 30, 2024

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 -0.74
June 30, 2024 -0.60
March 31, 2024 -0.52
December 31, 2023 -0.36
September 30, 2023 -0.45
June 30, 2023 -0.57
March 31, 2023 -0.46
December 31, 2022 -0.49
September 30, 2022 -0.41
June 30, 2022 -0.35
March 31, 2022 -0.41
December 31, 2021 -0.36
Date Value
September 30, 2021 -0.35
June 30, 2021 -0.31
March 31, 2021 -0.28
December 31, 2020 -0.32
September 30, 2020 -0.25
June 30, 2020 -0.38
March 31, 2020 -0.38
December 31, 2019 -0.28
September 30, 2019 0.0087
June 30, 2019 0.0127
March 31, 2019 -0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.74
Minimum
Sep 2024
-0.25
Maximum
Sep 2020
-0.4135
Average
-0.38
Median
Mar 2020

EPS Diluted (Quarterly) Benchmarks

Perspective Therapeutics Inc -0.21
Electromed Inc 0.16
Xtant Medical Holdings Inc -0.04
Myomo Inc -0.03
Catheter Precision Inc -2.01

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -109.12M
Total Expenses (Quarterly) 115.74M
Enterprise Value 3.471B
Earnings Yield -8.26%